Maximum Dosing of Hydralazine
The maximum recommended dose of hydralazine for treating hypertension is 300 mg daily in divided doses. 1
Dosing Guidelines
Initial Dosing
- Start with 10 mg four times daily for the first 2-4 days
- Increase to 25 mg four times daily for the remainder of the first week
- For the second week and beyond, increase to 50 mg four times daily 1
Maintenance and Maximum Dosing
- Adjust to the lowest effective dose for maintenance therapy
- Maximum daily dose: 300 mg 2, 1
- Most patients respond to doses below the maximum
- In resistant hypertension, hydralazine is typically added as a fifth-line agent at an initial dose of 25 mg three times daily, then titrated upward to maximum dose 3
Administration Schedule
- Typically administered in divided doses (3-4 times daily) due to its short duration of action 1
- Slow-release formulations may allow twice-daily dosing with adequate 24-hour blood pressure control 4
Special Considerations
Acetylator Status
- Acetylator status significantly affects dosing requirements:
Combination Therapy
- When used for heart failure with isosorbide dinitrate:
- Often combined with beta-blockers to counteract reflex tachycardia 6
- Lower doses may be effective when combined with thiazide diuretics and/or beta-blockers 1
Safety Considerations
Risk of Lupus-Like Syndrome
- The incidence of hydralazine-induced lupus syndrome is dose-dependent:
- No cases at 50 mg daily
- 5.4% incidence at 100 mg daily
- 10.4% incidence at 200 mg daily
- Higher risk in women (11.6%) than men (2.8%) 7
Monitoring
- Individual titration is essential to determine the lowest effective dose
- Monitor for signs of lupus-like syndrome, particularly in patients on higher doses
- Regular blood pressure monitoring to assess efficacy and adjust dosing as needed
Pediatric Dosing
- For children: maximum dose is 7.5 mg/kg/day up to 200 mg/day 3
- Usually administered in four divided doses daily
The maximum dose of 300 mg daily should be reserved for resistant cases, with careful monitoring for adverse effects, particularly the lupus-like syndrome which occurs more frequently at higher doses.